Caroline Loew serves as Executive at Mural Oncology plc, where they oversee executive responsibilities. Since joining the company, Caroline Loew has executed 6 insider transactions totaling $66.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved selling 293,059 shares valued at $0.
Caroline Loew currently holds 293,059 shares of Mural Oncology plc (MURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Caroline Loew has been a net seller of MURA stock. They have purchased $0 and sold $66.9K worth of shares.
Caroline Loew's most recent insider trade was on Dec 5, 2025, when they sold 293,059 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.43 |
| Discretionary |
| Jul 8, 2024 | MURA | $36.5K | Sale | 12,531 | $2.91 | Planned |
| Mar 1, 2024 | MURA | $0 | Award | 48,475 | $N/A | Discretionary |
| Dec 14, 2023 | MURA | $0 | Award | 167,276 | $N/A | Discretionary |
| Dec 14, 2023 | MURA | $0 | Award | 37,171 | $N/A | Discretionary |